Liraglutide 81607-0019-02
- Manufacturer
- Orbicular Pharmaceutical Technologies Private Limited
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 26, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA217234
Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Liraglutide | 6 mg/mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Selected Package
81607-0019-02Selected5 SYRINGE, PLASTIC in 1 CARTON (81607-019-02) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)
Other packages for this product(1)
3 SYRINGE, PLASTIC in 1 CARTON (81607-019-01) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)